Aradigm Health, a new benefits platform aimed at easing the financial sting of coverage for cell and gene therapies, has launched out of stealth. | Aradigm Health, new benefits platform aimed at ...

Later-stage financing deals for cell and gene therapy companies reflects a broader derisking trend in the pharma industry.

At the Cleveland Clinic, doctors are using a one-time gene-editing therapy that alters a patient’s own blood-forming stem cells to correct the genetic mutation responsible for the disease. Physicians ...

The federal government wants to make it easier for Medicaid patients to access new, curative treatments — one of the few initiatives on which President Donald Trump and the public health establishment ...

Caden Major was born with sickle cell disease – an inherited blood disorder affecting red blood cells. Now at 19 years old, ...

ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable residual disease (MRD)-negative responses in the first four patients with relapsed ...

TOMI Environmental Solutions, Inc.® ('TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, ...

A patient with synovial sarcoma, a soft-tissue cancer that usually occurs in the large joints of the arms and legs, is the ...

As head team physician for the New York Giants, I routinely have athletes asking about supposed ‘breakthrough’ stem cell ...

It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...

Backed by Italy-based Fondazione Telethon ETS, Waskyra, for Wiskott-Aldrich syndrome, is the first gene therapy from a non-profit sponsor to win FDA approval.

A small group of patients with an otherwise incurable form of T‑cell leukemia have seen their cancer driven into remission by ...